GL1X · GenesisL1 explorer

Research workbench

HIV-1 protease mutant V82A with potent antiviral inhibitor grl-98065

Analyse HIV-1 protease mutant V82A with potent antiviral inhibitor grl-98065 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2QD7
Type
protein
Length
198 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protease
EC
3.4.23.16
UniProt
P03367
Ligands
065, PO4
Pockets
1 · best druggability 0.70

Structure

x-ray diffraction · 1 distinct chain · 7% helix, 56% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BProtease (EC 3.4.23.16)protein997% helix, 56% strandP03367

Ligands and binding sites

  • 065 · (3r,3as,6ar)-hexahydrofuro[2,3-b]furan-3-yl(2s,3r)-3-hydroxy-4-(N-isobutylbenzo[d][1,3]dioxole-5-sulfonamido)-1-phenylbutan-2-ylcarbamate · ligand · chains A, B
  • PO4 · Phosphate ion · ion · 2 copies · chains A, B
  • DMS · Dimethyl sulfoxide · additive · 2 copies · chains A, B
  • GOL · Glycerol · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13920.700.8236065

Interfaces

1 interface between chains.

  • A–B · 1869 Ų buried · 37 hydrogen bonds · protein-protein

Compared structures

  • 2QD7 · HIV-1 Protease Mutant V82A with potent Antiviral inhibitor GRL-98065 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.